  0 Table of Contents |
  1 Patient Monitoring Outcome Home Page |
| 2 General Recommendations |
| 3 Terminologies |
| 4 Overview Carepaths |
| 5 Carepath Heart failure |
| 6 Carepath Holter Monitoring |
| 7 Carepath NEWS (National Early Warning Score) |
| 8 Carepath TOTeM |
| 9 Carepath OPAT |
| 10 Carepath Antitumoral therapy |
| 11 Carepath Perioperative care - abdominal |
| 12 Overview carepath LOINC |
| 13 Overview caresets |
| 14 Special careset - home hospitalization |
| 15 Home hosp - OPAT |
| 16 Home hosp - Antitumoral therapy |
| 17 Home hosp - Mappingtables |
| 18 Useful Downloads |
| 19 Acknowledgments, licenses and copyrights |
| 20 IG Change History |
 21 Artifacts Summary |
 21.1 Home Hospitalization Encounter Logical Model |
| 21.2 Home Hospitalization QuestionnaireResponse Logical Model |
| 21.3 ONCO Azacitidine Questionnaire Logical Model |
| 21.4 ONCO Bortezomib Questionnaire Logical Model |
| 21.5 ONCO Daratumumab Questionnaire Logical Model |
| 21.6 ONCO Fulvestrant Questionnaire Logical Model |
| 21.7 ONCO Trastuzumab Questionnaire Logical Model |
| 21.8 OPAT Continuous Infusion Questionnaire Logical Model |
| 21.9 OPAT Short IV Questionnaire Logical Model |
| 21.10 Appetite Observation |
| 21.11 Bladder continence Observation |
| 21.12 CLinical note Observation |
| 21.13 Drain fluid Observation |
| 21.14 Holter Diagnostic Report |
| 21.15 Holter Observation |
| 21.16 Home Hospitalization Careset Encounter |
| 21.17 Home Hospitalization Careset Questionnaire Response |
| 21.18 Nausea Observation |
| 21.19 ONCO Azacitidine Nursing Questionnaire |
| 21.20 ONCO Bortezomib Nursing Questionnaire |
| 21.21 ONCO Daratumumab Nursing Questionnaire |
| 21.22 ONCO Fulvestrant Nursing Questionnaire |
| 21.23 ONCO Trastuzumab Nursing Questionnaire |
| 21.24 OPAT Continuous Infusion Nursing Questionnaire |
| 21.25 OPAT Short-Duration IV Nursing Questionnaire |
| 21.26 Painkiller usage Observation |
| 21.27 Stool Observation |
| 21.28 Surgical wound pain observation |
| 21.29 Wexner/CCIS score Observation |
| 21.30 0-10 scale, 0.5 increments, Very well to Very poor |
| 21.31 Continence level |
| 21.32 Fluid Drain Value Set |
| 21.33 Heart Failure Symptom Codes |
| 21.34 Holter Event Codes |
| 21.35 Holter Observation Component Codes |
| 21.36 Holter Report Code |
| 21.37 Pain severity - 0-10 verbal numeric rating |
| 21.38 Symptom Severity Scale |
| 21.39 Yes/No Value Set |
| 21.40 Abdominal pain example |
| 21.41 Appetite example |
| 21.42 Azacitidine questionnaire home hospitalization |
| 21.43 Azacitidine questionnairesponse home hospitalization |
| 21.44 Bladder Continence |
| 21.45 BloodPressureExample |
| 21.46 BloodPressureExample2 |
| 21.47 BodyTemperatureExample |
| 21.48 BodyTemperatureExample2 |
| 21.49 BodyWeightExample |
| 21.50 BodyWeightExample2 |
| 21.51 Bortezomib questionnaire home hospitalization |
| 21.52 CareTeam Katheter |
| 21.53 CareTeam OPAT |
| 21.54 CareTeam Spoed |
| 21.55 Catheter moved or removed example |
| 21.56 Catheter observation for OPAT patient |
| 21.57 Clinical note |
| 21.58 Daratumumab questionnaire home hospitalization |
| 21.59 Diarrhea example |
| 21.60 Distended abdomen example |
| 21.61 Drain fluid output example |
| 21.62 Fulvestrant questionnaire home hospitalization |
| 21.63 General practitioner example |
| 21.64 HeartRateExample |
| 21.65 HeartRateExample2 |
| 21.66 Holter AFib Episode |
| 21.67 Holter DiagnosticReport Example |
| 21.68 Holter Supraventricular Event |
| 21.69 Home hospitalization encounter for subcutaneous injection |
| 21.70 incontinence assessment using the wexner/CCIS score |
| 21.71 Leakage catheter example |
| 21.72 Level of responsiveness example |
| 21.73 National Early Warning Score example |
| 21.74 Nausea example |
| 21.75 Nausea example 2 |
| 21.76 ONCO SDC Questionnaire with Extraction Definitions (Trastuzumab) |
| 21.77 OPAT appointment example |
| 21.78 OPAT consultation encounter example |
| 21.79 OPAT document example (composition) |
| 21.80 OPAT patient example |
| 21.81 OPAT questionnaire home hospitalization |
| 21.82 OPAT questionnaireresponse home hospitalization |
| 21.83 OPAT SDC Questionnaire with Extraction Definitions |
| 21.84 OPAT short IV questionnaire home hospitalization |
| 21.85 Organization example for OPAT document |
| 21.86 Orthopneu example |
| 21.87 Overarching CareTeam Home Hospitalization |
| 21.88 OxygenSaturationExample |
| 21.89 OxygenSaturationExample2 |
| 21.90 Pain during urination example |
| 21.91 Pain in calves example |
| 21.92 Pain infection site example |
| 21.93 Pain puncture wounds example |
| 21.94 Pain surgical wounds example |
| 21.95 Pain surgical wounds example 2 |
| 21.96 Redness puncture wounds example |
| 21.97 Reduced appetite example |
| 21.98 Relevante medische voorgeschiedenis |
| 21.99 RespiratoryRateExample |
| 21.100 RespiratoryRateExample2 |
| 21.101 Shortness of breath example |
| 21.102 Shoulder pain example |
| 21.103 Stool assessment using the bristol stool form score |
| 21.104 Symptoom: Ademhalingsproblemen |
| 21.105 Symptoom: Andere |
| 21.106 Symptoom: Blaren |
| 21.107 Symptoom: Braken |
| 21.108 Symptoom: Candidiase |
| 21.109 Symptoom: Diarree |
| 21.110 Symptoom: Gewrichtspijn |
| 21.111 Symptoom: Huiduitslag |
| 21.112 Symptoom: Jeuk |
| 21.113 Symptoom: Misselijkheid |
| 21.114 Symptoom: Moe |
| 21.115 Symptoom: Observatie andere - specifieer |
| 21.116 Symptoom: Obstipatie |
| 21.117 Symptoom: Pijn |
| 21.118 Symptoom: Rillingen |
| 21.119 Symptoom: Verminderde eetlust |
| 21.120 Symptoom: Zwelling |
| 21.121 Temperature observation for OPAT patient |
| 21.122 Trastuzumab questionnaire home hospitalization |
| 21.123 Usage of pain killers |
 21.124 UZL consultation location example |
